Literature DB >> 25530608

Trends in operative caseload and mortality rates after radical cystectomy for bladder cancer in England for 1998-2010.

Luke S Hounsome1, Julia Verne2, John S McGrath3, David A Gillatt4.   

Abstract

BACKGROUND: The Improving Outcomes in Urological Cancers guidelines recommended centralisation of cystectomy services to improve outcomes for bladder cancer (BCa) patients.
OBJECTIVE: To investigate trends in all-cause and cause-specific survival to see if there was an improvement in survival after centralisation was implemented. To analyse trends in the number of acute hospital trusts undertaking cystectomy. DESIGN, SETTING, AND PARTICIPANTS: We used routine data to capture information on radical cystectomy (RC) in BCa patients aged 20 yr and older between 1998 and 2010 (n=16,033). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We calculated 30-d and 90-d mortality, and 30-d, 90-d, 1-yr, and 5-yr survival. The average number of RCs per trust was derived. Trends were identified using regression analysis. RESULTS AND LIMITATIONS: The 30-d crude mortality decreased from 5.2% to 2.1% (p<0.001) and 90-d crude mortality decreased from 10.3% to 5.1% (p<0.001). There was an increase in 30-d relative survival from 96% to 98% (p<0.001), in 90-d relative survival from 91% to 96% (p<0.001), in 1-yr relative survival from 71% to 80% (p<0.001), and in 5-yr relative survival from 49% to 56% (2004-2006 data; p<0.001). The mean number of RCs performed by trusts in England increased from six to 24 (p<0.001). Smoking status and stage at diagnosis were not available.
CONCLUSIONS: Survival after RC has increased alongside decreases in short-term mortality. There is little evidence of a cohort effect. The trends in survival are linear and we conclude that the continued survival improvements are a result of a combination of service improvements that include service reconfiguration, improved surgical training, neoadjuvant chemotherapy, enhanced recovery principles, and continued improvements in perioperative care. PATIENT
SUMMARY: We analysed routinely collected hospital data. Outcomes for patients who undergo cystectomy have improved for all age groups. This is likely to be due to a combination of changes in practice.
Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Centralisation; Cystectomy; Postoperative mortality; Survival trends

Mesh:

Year:  2014        PMID: 25530608     DOI: 10.1016/j.eururo.2014.12.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  14 in total

Review 1.  The Role of Robotics in the Invasive Management of Bladder Cancer.

Authors:  Pramit Khetrapal; Wei Shen Tan; Benjamin Lamb; Melanie Tan; Hilary Baker; James Thompson; Ashwin Sridhar; John D Kelly; Tim Briggs
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

2.  Urinary tract infection after radical cystectomy: a vexing problem despite prophylactic antibiotics.

Authors:  Joseph Y Clark; Jay D Raman
Journal:  Transl Androl Urol       Date:  2019-12

Review 3.  Complications of Radical Cystectomy and Orthotopic Reconstruction.

Authors:  Wei Shen Tan; Benjamin W Lamb; John D Kelly
Journal:  Adv Urol       Date:  2015-11-30

Review 4.  Influence of hospital volume on nephrectomy mortality and complications: a systematic review and meta-analysis stratified by surgical type.

Authors:  Ray C J Hsu; Theodosia Salika; Jonathan Maw; Georgios Lyratzopoulos; Vincent J Gnanapragasam; James N Armitage
Journal:  BMJ Open       Date:  2017-09-05       Impact factor: 2.692

5.  Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model.

Authors:  Zongren Wang; Han Xiao; Guangyan Wei; Ning Zhang; Mengchao Wei; Zebin Chen; Zhenwei Peng; Sui Peng; Shaopeng Qiu; Heping Li; Jianting Long
Journal:  BMC Cancer       Date:  2018-11-12       Impact factor: 4.430

6.  An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer.

Authors:  Andrew J Sutton; John V Lamont; R Mark Evans; Kate Williamson; Declan O'Rourke; Brian Duggan; Gurdeep S Sagoo; Cherith N Reid; Mark W Ruddock
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

7.  Impact of hospital nephrectomy volume on intermediate- to long-term survival in renal cell carcinoma.

Authors:  Ray C J Hsu; Matthew Barclay; Molly A Loughran; Georgios Lyratzopoulos; Vincent J Gnanapragasam; James N Armitage
Journal:  BJU Int       Date:  2019-07-15       Impact factor: 5.588

Review 8.  Emerging treatments for bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer.

Authors:  Hyung Suk Kim; Ho Kyung Seo
Journal:  Investig Clin Urol       Date:  2021-05-27

9.  Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy.

Authors:  Michael Froehner; Rainer Koch; Matthias Hübler; Ulrike Heberling; Vladimir Novotny; Stefan Zastrow; Oliver W Hakenberg; Manfred P Wirth
Journal:  BMC Urol       Date:  2018-10-22       Impact factor: 2.264

10.  Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010.

Authors:  Ray C J Hsu; Matthew Barclay; Molly A Loughran; Georgios Lyratzopoulos; Vincent J Gnanapragasam; James N Armitage
Journal:  BJU Int       Date:  2018-04-20       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.